Cargando…

Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study

OBJECTIVE: Examine whether the relationship between the pooled cohort equations (PCE) predicted 10-year risk for atherosclerotic cardiovascular disease (ASCVD) and absolute risk for ASCVD is modified by socioeconomic status (SES). DESIGN: Population-based longitudinal cohort study—Atherosclerosis Ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henderson, Kamal, Kaufman, Brystana, Rotter, Jason S, Stearns, Sally, Sueta, Carla A A, Foraker, Randi, Ho, P Michael, Chang, Patricia P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644311/ https://www.ncbi.nlm.nih.gov/pubmed/36343998 http://dx.doi.org/10.1136/bmjopen-2021-058777

Ejemplares similares

Lipid-lowering pharmacotherapy and socioeconomic status: atherosclerosis risk in communities (ARIC) surveillance study
por: Kitzmiller, Joseph P, et al.
Publicado: (2013)

Neighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: Atherosclerosis risk in communities (ARIC) community surveillance
por: Foraker, Randi E, et al.
Publicado: (2010)

Plasma Testosterone Levels and Atherosclerotic Plaque Gene Expression in Men With Advanced Atherosclerosis
por: Groepenhoff, Floor, et al.
Publicado: (2021)

Coronary Atherosclerotic Disease and Cancer: Risk Factors and Interrelation
por: Li, Jinjing, et al.
Publicado: (2022)

Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor
por: Nahmias, Avital, et al.
Publicado: (2020)

Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

(Pro)renin Receptor Inhibition Reduces Plasma Cholesterol and Triglycerides but Does Not Attenuate Atherosclerosis in Atherosclerotic Mice
por: Ye, Dien, et al.
Publicado: (2021)

Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
por: Aday, Aaron W., et al.
Publicado: (2019)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

Common variable immunodeficiency—an independent risk factor for atherosclerotic cardiovascular diseases
por: Mattila, Juho, et al.
Publicado: (2023)

Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China
por: Liu, Hui, et al.
Publicado: (2023)

Retrospective angiographic study to determine the effect of atherosclerotic stenoses of upstream arteries on the degree of atherosclerosis in distal vascular territories
por: Rehwald, Rafael, et al.
Publicado: (2016)

Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)

Editorial: Epidemiology and clinical researches in atherosclerosis and cardiovascular disease
por: Gao, Darui, et al.
Publicado: (2023)

Socioeconomic inequalities in coronary heart disease risk in older age: contribution of established and novel coronary risk factors
por: RAMSAY, S E, et al.
Publicado: (2009)

Plasma Oxylipins: A Potential Risk Assessment Tool in Atherosclerotic Coronary Artery Disease
por: Le, D. Elizabeth, et al.
Publicado: (2021)

LBODP026 Early Atherosclerosis In High-risk Women With Pcos
por: Wu, Xiaoying, et al.
Publicado: (2022)

Inflammatory Mediators in Atherosclerotic Vascular Remodeling
por: Evans, Bryce R., et al.
Publicado: (2022)

Epigenetic modifications as therapeutic targets in atherosclerosis: a focus on DNA methylation and non-coding RNAs
por: Sum, Hashum, et al.
Publicado: (2023)

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
por: Gourdy, Pierre, et al.
Publicado: (2023)

The Predictive Value of Carotid Ultrasonography With Cardiovascular Risk Factors—A “SPIDER” Promoting Atherosclerosis
por: Li, Hongwei, et al.
Publicado: (2021)

Circulating Autoantibodies Recognizing Immunodominant Epitopes From Human Apolipoprotein B Associate With Cardiometabolic Risk Factors, but Not With Atherosclerotic Disease
por: Marchini, Timoteo, et al.
Publicado: (2022)

The effect of plaque morphology, material composition and microcalcifications on the risk of cap rupture: A structural analysis of vulnerable atherosclerotic plaques
por: Corti, Andrea, et al.
Publicado: (2022)

Artificial intelligence in atherosclerotic disease: Applications and trends
por: Kampaktsis, Polydoros N., et al.
Publicado: (2023)

Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study
por: Kats, Dmitry, et al.
Publicado: (2017)

Interaction analysis of the new pooled cohort equations for 10-year atherosclerotic cardiovascular disease risk estimation: a simulation analysis
por: Schiros, Chun G, et al.
Publicado: (2015)

Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study
por: Guan, Xu-Min, et al.
Publicado: (2023)

Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study
por: Crawford, Stephen O, et al.
Publicado: (2010)

Evaluating the longitudinal risk of social vigilance on atherosclerosis: study protocol for the North Texas Heart Study
por: Ruiz, John M, et al.
Publicado: (2017)

Development and validation of a carotid atherosclerosis risk prediction model based on a Chinese population
por: Huang, Guoqing, et al.
Publicado: (2022)

Increasing use of systems science in cardiovascular disease prevention to understand how to address geographic health disparities in communities with a disproportionate burden of risk
por: Bauer, Kyla L., et al.
Publicado: (2023)

Aortic Stiffness: Epidemiology, Risk Factors, and Relevant Biomarkers
por: Angoff, Rebecca, et al.
Publicado: (2021)

The Mechanism and Role of N(6)-Methyladenosine (m(6)A) Modification in Atherosclerosis and Atherosclerotic Diseases
por: Tan, Quandan, et al.
Publicado: (2022)

Cardiovascular Disease and Patterns of Change in Functional Status Over 15 Years: Findings From the Atherosclerosis Risk in Communities (ARIC) Study
por: Kucharska‐Newton, Anna, et al.
Publicado: (2017)

Prospective Comparison of Plasma Biomarker and Traditional Risk Factor Profiles for Incident Isolated Atherosclerotic Disease and Incident Isolated Abdominal Aortic Aneurysm
por: Acosta, Stefan, et al.
Publicado: (2022)

Comparable Ascertainment of Newly-Diagnosed Atrial Fibrillation Using Active Cohort Follow-Up versus Surveillance of Centers for Medicare and Medicaid Services in the Atherosclerosis Risk in Communities Study
por: Bengtson, Lindsay G. S., et al.
Publicado: (2014)

E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease
por: Poels, Kikkie, et al.
Publicado: (2020)

Electrophysiological ventricular substrate of stroke: a prospective cohort study in the Atherosclerosis Risk in Communities (ARIC) study
por: Johnson, John A, et al.
Publicado: (2021)

Electrocardiographic markers of atrial cardiomyopathy and risk of heart failure in the multi-ethnic study of atherosclerosis (MESA) cohort
por: Ahmad, Muhammad Imtiaz, et al.
Publicado: (2023)

Association of sex and cardiovascular risk factors with atherosclerosis distribution pattern in lower extremity peripheral artery disease
por: Baretella, Oliver, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i6jdpigjfhdk7barf4b2i4qeqj